Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

HCF 2018 Depate introduction: Roger Drew


Published on

DEBATE: Can product stewardship replace regulation? Case nanomaterials
Presentation: Roger Drew, Toxicologist, ToxConsult Ltd, Australia

  • Be the first to comment

  • Be the first to like this

HCF 2018 Depate introduction: Roger Drew

  1. 1. Debate: "Can product stewardship replace regulation? Case nanomaterials" Moderator: Roger Drew, Toxicology Consultant, Australia. Debaters: David Azoulay, Managing Attorney, CIEL, Switzerland. David Warheit, Technical Fellow − Toxicology and Risk Assessment, The Chemours Company, US. Helsinki Chemicals Forum June 15th 2018
  2. 2. 2 Nanomaterials (NMs) – here, there and every where. Abound in human environment: • In nature. • Food. • Consumer products. • Therapeutics and diagnostics. • Industrial processes. • Day to day articles.
  3. 3. 3
  4. 4. 4 Nanomaterials (NMs) – here, there and every where. Potentially as diverse as chemicals with similar challenges for safety management Concern is with manufactured NMs. - Each with unique properties (??). - Very few tested. - How safe? - What’s the exposure? - What’s the risk?
  5. 5. 5 - Chemical regulation has evolved over the last 50+ years. - Predilection towards risk and rule based regulation. - Amount of information required to assess risk tends to be based on the amount of chemical produced/marketed. - Chemical product stewardship = Responsible Care ® - Evolved over 30+ years to build trust and confidence. - A set of Core Principles practiced in 68 global economies. - Has considerably decreased injuries and incidents. In these paradigms can “chemical” be replaced by “nanomaterial” ?
  6. 6. Questions from the forum organiser: • Is chemical legislation robust enough for NM’s? • What’s the role of industry product stewardship? • How can companies show due diligence? 6 • Can workers and consumers [researchers] have confidence in safe use of NM, or should there be explicit testing requirements?
  7. 7. 7 With respect to understanding hazards and safe use, what are the challenges/benefits with product stewardship or regulation for NM’s? David Azoulay: What detracts from product stewardship but is attractive about regulation? David Warheit: What are the benefits of product stewardship and the issues with regulation?